Related Experiment Video
Updated: Aug 17, 2026

Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
Published on: December 19, 2014
Cavitating cryptococcal pneumonia in the immunocompetent host
1Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Outram Road, Singapore 169608.
Introduction:
Isolated cryptococcal pneumonia in the immunocompetent host is a rare infection. Indications for treatment and its duration are currently not defined.
Clinical Picture:
Three patients presented with cavitating cryptococcal pneumonia.
Treatment:
They were treated with oral fluconazole.
Outcome:
Improvement was evident clinically, radiologically and serologically. Fluconazole was continued until serum cryptococcal antigen (SCA) levels were negative in our patients as they had manifestations such as haemoptysis, cavitating or multi-lobar pneumonia and relatively high antigen levels, suggesting potentially serious disease.
Conclusions:
Fluconazole is effective and safe for the treatment of cryptococcal pneumonia in the immunocompetent host. Although the role of monitoring SCA levels in the immunocompetent host is currently unclear, it may be an indication of infective burden and the benefits of longer treatment seem to outweigh the risks.
Insights
Oral fluconazole effectively treats cryptococcal pneumonia in immunocompetent patients. Treatment continued until serum cryptococcal antigen (SCA) levels normalized, showing clinical, radiological, and serological improvement.
Area of Science:
- Infectious Diseases
- Pulmonology
- Mycology
Background:
- Cryptococcal pneumonia is rare in immunocompetent individuals.
- Treatment guidelines and duration are undefined for this condition.
- Cavitating pulmonary cryptococcosis presents unique clinical challenges.
Purpose of the Study:
- To evaluate the efficacy and safety of oral fluconazole for cryptococcal pneumonia in immunocompetent hosts.
- To explore the role of serum cryptococcal antigen (SCA) monitoring in treatment management.
Main Methods:
- Retrospective analysis of three immunocompetent patients with cavitating cryptococcal pneumonia.
- Treatment with oral fluconazole.
- Monitoring of clinical, radiological, and serological parameters, including SCA levels.
Main Results:
- All three patients showed significant clinical, radiological, and serological improvement.
- Fluconazole treatment was continued until negative SCA levels were achieved.
- Manifestations like hemoptysis and cavitating pneumonia indicated potentially severe disease.
Conclusions:
- Oral fluconazole is an effective and safe treatment option for cryptococcal pneumonia in immunocompetent hosts.
- Monitoring SCA levels may indicate disease burden and guide treatment duration.
- Extended treatment duration appears beneficial, outweighing potential risks.
Related Concept Videos
Cryptococcal Meningitis
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Candidiasis
Cytomegalovirus Disease
Brain Abscess l: Introduction